We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Coated Brain Aneurysm Coiling Devices Found Less Effective

By HospiMedica staff writers
Posted on 03 Mar 2008
A new study of patients suffering from a ruptured brain aneurysm has found that expensive new coiling devices are no more effective than bare platinum coils at preventing aneurysms from recurring.

Researchers at the University of Cincinnati (UC, OH, USA) and University Hospital (Cincinnati, OH, USA), conducted a retrospective analysis of 100 patients suffering from a ruptured brain aneurysm and evaluated the risk of intracranial aneurysm recurrence after endovascular treatment with each of three different kinds of coils. More...
To determine whether the new strategies indicated an improvement, the research team analyzed the outcomes during a 3 ½-year period of successively treated patients who had suffered ruptured aneurysms of medium size (five to 15 millimeters in diameter).

The study found that at the end of one year, the bare platinum coils were associated with the least number of repeated treatments. The percentage requiring repeated treatment was 6.4% in the platinum coils group, 11.5% in the expanding gel-coating group, and 20.9% in the polymer-coating group. The findings were presented at the International Stroke Conference held during February 2008 in New Orleans (LA, USA).

"The purpose of our study was to assess the effectiveness of these new treatments,” said lead author Andrew Ringer, M.D., director of endovascular neurosurgery and associate professor of neurosurgery at UC. "We found that neither of these newer, and more costly coils performed any better than the bare platinum coils. The results suggest the possibility that a factor, or factors, other than coil-surface coating may be responsible for reducing aneurysm recurrence.”

Coils may occasionally compact within the aneurysm, causing blood to flow back into the aneurysm, making repeated treatment necessary. To address this issue, polymer coated coils are designed to promote tissue healing at the neck of the aneurysm, while gel coated coils are designed to expand inside the aneurysm when exposed to blood, filling all the nooks and crannies.


Related Links:
University of Cincinnati
University Hospital

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.